Paradigm Capital Management Inc. NY Increases Stock Position in Bath & Body Works, Inc. $BBWI

Paradigm Capital Management Inc. NY boosted its position in Bath & Body Works, Inc. (NYSE:BBWI) by 140.5% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 481,100 shares of the company’s stock after acquiring an additional 281,100 shares during the period. Paradigm Capital Management Inc. NY’s holdings in Bath & Body Works were worth $8,982,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the company. Global Retirement Partners LLC bought a new position in shares of Bath & Body Works during the fourth quarter valued at about $31,000. Activest Wealth Management bought a new stake in shares of Bath & Body Works in the fourth quarter worth about $32,000. Geneos Wealth Management Inc. grew its stake in shares of Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after purchasing an additional 801 shares during the last quarter. Parallel Advisors LLC increased its holdings in Bath & Body Works by 42.6% during the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock valued at $38,000 after purchasing an additional 567 shares during the period. Finally, Danske Bank A S purchased a new position in Bath & Body Works during the 3rd quarter valued at about $39,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Price Performance

Shares of NYSE BBWI opened at $19.92 on Friday. Bath & Body Works, Inc. has a 1 year low of $14.27 and a 1 year high of $32.32. The company’s 50-day moving average is $19.82 and its 200 day moving average is $20.44. The stock has a market capitalization of $4.02 billion, a P/E ratio of 5.60, a P/E/G ratio of 1.91 and a beta of 1.38.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.29 by $0.03. The business had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.36 billion. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. Bath & Body Works’s quarterly revenue was down 3.2% compared to the same quarter last year. During the same period last year, the business posted $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. Research analysts anticipate that Bath & Body Works, Inc. will post 2.63 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, June 19th. Stockholders of record on Friday, June 5th were given a $0.20 dividend. The ex-dividend date of this dividend was Friday, June 5th. This represents a $0.80 annualized dividend and a dividend yield of 4.0%. Bath & Body Works’s dividend payout ratio is currently 22.47%.

Wall Street Analyst Weigh In

BBWI has been the subject of a number of recent analyst reports. TD Cowen upped their price target on Bath & Body Works from $20.00 to $25.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Wells Fargo & Company lifted their price objective on Bath & Body Works from $25.00 to $26.00 and gave the stock an “overweight” rating in a research report on Tuesday, June 23rd. Raymond James Financial reissued a “market perform” rating on shares of Bath & Body Works in a research note on Wednesday, May 27th. The Goldman Sachs Group downgraded Bath & Body Works from a “neutral” rating to a “sell” rating and decreased their target price for the company from $23.00 to $19.00 in a report on Wednesday, July 8th. Finally, UBS Group dropped their price target on Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, May 20th. Three equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $22.00.

Bath & Body Works Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.